Toumi, Mondher

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

Drummond, M. F., Neumann, P. J., Sullivan, S. D., Fricke, F.-U., Tunis, S., Dabbous, O., & Toumi, M. (2019) · Value in Health

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 92

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

Thomas, S. H. L., Drici, M. D., Hall, G. C., Crocq, M. A., Everitt, B., Lader, M. H., Jeunne, C. L., Naber, D., Priori, S., Sturkenboom, M., et al. (2010) · Acta Psychiatrica Scandinavica

Schizophrenia research and treatmentPharmacovigilance and Adverse Drug Reactions

Cited by 67

Cultural differences in stigma surrounding schizophrenia: Comparison between Central Europe and North Africa

Angermeyer, M. C., Carta, M. G., Matschinger, H., Millier, A., Refaï, T., Schomerus, G., & Toumi, M. (2016) · British Journal of Psychiatry

Mental Health Treatment and AccessSchizophrenia research and treatment

Cited by 52

Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database

Kunz, D., Bineau, S., Maman, K., Milea, D., & Toumi, M. (2012) · Expert Opinion on Pharmacotherapy

Sleep and related disordersCircadian rhythm and melatonin

Cited by 37

Predictors of employment status change over 2 years in people with schizophrenia living in Europe

Marwaha, S., Johnson, S., Bebbington, P. E., Angermeyer, M. C., Brugha, T. S., Azorin, J.-M., Killian, R., Hansen, K., & Toumi, M. (2009) · Epidemiology and Psychiatric Sciences

Schizophrenia research and treatmentEmployment and Welfare Studies

Cited by 31